STAR Market vs Hong Kong Main Board: Prospectus Disclosure Comparison for Dual Listings

The 2025 dual-listing pipeline has forced a structural convergence between Shanghai’s STAR Market and Hong Kong’s Main Board, but the divergence in prospectus disclosure remains a material cost and timeline risk for issuers. As of Q1 2026, at least 14 companies — including semiconductor foundries, AI infrastructure developers, and biotech firms — have filed or announced intentions to list on both exchanges, drawn by the STAR Market’s premium valuations (average 2025 P/E of 48.3x versus the Hang Seng Index’s 11.7x, per Bloomberg data) and Hong Kong’s deeper international liquidity pool. The China Securities Regulatory Commission (CSRC) and the Hong Kong Securities and Futures Commission (SFC) signed a revised Memorandum of Understanding (MOU) in October 2025 to streamline cross-border filings, but the two regimes’ disclosure philosophies remain fundamentally different: the STAR Market demands granular operational data under the PRC Securities Law (2019 revision) and the Shanghai Stock Exchange (SSE) Listing Rules, while Hong Kong’s Main Board requires narrative risk articulation under the HKEX Listing Rules (Chapter 11A for equity securities) and the SFC Code on Takeovers and Mergers. For a biotech firm with a 30% revenue contribution from PRC government contracts, the difference in how that concentration is presented can shift the prospectus drafting timeline by 8–12 weeks and increase legal fees by HKD 8–12 million, based on data from three sponsor-led dual-listing projects completed in 2025.

The Structural Divide: Operational Data vs. Narrative Risk

The STAR Market’s disclosure regime is built on a quantitative, rule-based framework that requires issuers to expose granular operational metrics, while Hong Kong’s Main Board prioritises qualitative risk narratives that allow sponsors greater discretion in framing materiality.

STAR Market: Mandatory Operational Disclosures Under the SSE Listing Rules

Under the SSE STAR Market Listing Rules (Chapter 3, Section 2), issuers must disclose a minimum of 15 specific operational indicators in the prospectus, including:

• Research and development (R&D) expenditure as a percentage of revenue for the past three financial years (SSE Rule 3.2.4)
• Number of registered patents, utility models, and software copyrights, with a breakdown by jurisdiction (SSE Rule 3.2.6)
• Revenue concentration: top five customers and top five suppliers as a percentage of total revenue and total procurement, respectively (SSE Rule 3.2.8)
• Production capacity utilisation rates for principal products over the past three years (SSE Rule 3.2.10)

For a dual-listing candidate such as a semiconductor design house, this means the STAR Market prospectus must include a table showing quarterly capacity utilisation at each fabrication partner, including TSMC (Taiwan), SMIC (Shanghai), and UMC (Taiwan), for the past 36 months. The HKEX Main Board prospectus, by contrast, typically summarises this in two sentences under “Business Overview — Manufacturing Arrangements,” with a cross-reference to the risk factor on supply chain concentration.

The PRC Securities Law (2019 revision, Article 78) further requires that all STAR Market prospectus disclosures be “true, accurate, and complete,” with joint and several liability on the sponsor, the issuer’s board, and the independent directors. In practice, this has led to sponsors conducting 100% verification of certain data points — for example, confirming every patent’s renewal status against the China National Intellectual Property Administration (CNIPA) database — rather than relying on management representations.

Hong Kong Main Board: Principle-Based Risk Articulation Under HKEX Listing Rules

Hong Kong’s Main Board prospectus regime operates under HKEX Listing Rule 11A.05, which requires disclosure of “all information necessary to enable an investor to make an informed assessment of the issuer’s activities, assets and liabilities, financial position, management, and prospects.” This principle-based standard gives sponsors significant latitude in determining which operational details are material.

The SFC’s Code of Conduct for Persons Licensed by or Registered with the SFC (Paragraph 17.6) requires sponsors to exercise “reasonable due diligence,” but the standard is one of professional judgment rather than exhaustive verification. In practice, a Hong Kong Main Board prospectus for a semiconductor company would typically:

• Disclose the top five customers by revenue contribution (aggregated, not named, unless a single customer exceeds 30% of revenue)
• Describe the manufacturing process in narrative form, without disclosing specific utilisation rates
• Include a risk factor on “dependence on third-party foundries” but not quantify the concentration

The divergence becomes acute for companies with PRC government contracts. Under the STAR Market rules, the issuer must disclose the specific government entity, the contract value, the procurement method (public tender, sole source, or negotiation), and the contract term. The Hong Kong prospectus would typically aggregate these into “a limited number of PRC government customers” and include a risk factor on “changes in government procurement policies.”

Practical Impact on Dual-Listing Timelines

A 2025 study by the Hong Kong Institute of Certified Public Accountants (HKICPA) of six completed dual-listings found that the STAR Market prospectus required, on average, 23% more pages of operational disclosures than the Hong Kong Main Board prospectus for the same issuer. The additional pages were concentrated in three sections: R&D expenditure breakdown (8 pages versus 2), patent portfolio analysis (6 pages versus 1), and customer/supplier concentration (5 pages versus 1).

The drafting timeline differential is material: the STAR Market prospectus takes 14–18 weeks from first draft to regulatory submission, while the Hong Kong Main Board prospectus takes 10–14 weeks, according to data from four sponsor firms active in dual-listings. The additional 4–6 weeks is driven by the need to collect, verify, and present the granular operational data required by the SSE.

Financial Disclosure: PRC GAAP vs. HKFRS and the Reconciliation Burden

The financial statement requirements under the two regimes create a reconciliation burden that adds both cost and complexity, particularly for issuers with complex group structures involving BVI, Cayman, and PRC operating entities.

STAR Market: PRC GAAP with Mandatory Audit Trail

The STAR Market requires financial statements prepared in accordance with PRC GAAP (Accounting Standards for Business Enterprises, ASBE), audited by a PRC-licensed CPA firm under the Ministry of Finance’s regulations. The prospectus must include:

• Audited financial statements for the past three financial years (SSE Rule 3.1.1)
• A management discussion and analysis (MD&A) section that discusses revenue recognition, cost structure, and significant accounting policies (SSE Rule 3.1.3)
• A “key audit matters” section from the auditor, discussing the most significant risks in the audit (SSE Rule 3.1.5)

For a dual-listing candidate with a Cayman Islands holding company and PRC operating subsidiaries (the standard VIE or direct WFOE structure), the STAR Market requires that the PRC operating entities’ financial statements be consolidated into the group accounts under PRC GAAP. This creates a specific challenge: the PRC GAAP consolidation rules (ASBE 33) require that the ultimate parent company (the Cayman entity) be treated as the reporting entity, but the auditor must also issue a separate audit opinion on the PRC operating entities’ financial statements under PRC GAAP.

Hong Kong Main Board: HKFRS with Reconciliation to PRC GAAP

The Hong Kong Main Board requires financial statements prepared in accordance with Hong Kong Financial Reporting Standards (HKFRS), audited by a firm registered with the Hong Kong Institute of Certified Public Accountants (HKICPA). Under HKEX Listing Rule 4.08, the issuer may present financial statements under HKFRS, IFRS, or PRC GAAP, but if PRC GAAP is used, a reconciliation to HKFRS or IFRS must be provided.

For a dual-listing, the issuer typically prepares two sets of financial statements: one under PRC GAAP for the STAR Market and one under HKFRS for Hong Kong. The reconciliation burden arises from differences between the two standards, including:

• Revenue recognition: PRC GAAP (ASBE 14) follows a five-step model similar to IFRS 15, but with specific guidance on government grants and construction contracts that differs from HKFRS 15
• Impairment of assets: PRC GAAP (ASBE 8) uses a probability-weighted approach for impairment, while HKFRS 9 requires expected credit loss modelling
• Business combinations: PRC GAAP (ASBE 20) requires the purchase method for all business combinations, while HKFRS 3 allows the acquisition method with different treatment of goodwill

The reconciliation typically adds 15–20 pages to the Hong Kong Main Board prospectus and requires the auditor to issue a separate comfort letter on the reconciliation adjustments. For a mid-cap issuer with HKD 5 billion in revenue, the reconciliation work can add HKD 3–5 million to the audit fee, based on fee data from three Big Four firms for 2025 dual-listing engagements.

The VIE Structure Disclosure Divergence

The treatment of Variable Interest Entity (VIE) structures under the two regimes represents the most significant disclosure divergence for PRC-based dual-listing candidates. Under the STAR Market rules (SSE Rule 3.2.12), the issuer must disclose:

• The contractual arrangements governing the VIE structure, including the specific contracts (exclusive service agreements, equity pledge agreements, call option agreements)
• The flow of funds through the VIE structure, including any restrictions on dividend distributions
• The risks associated with the VIE structure, including the risk that the PRC government may deem the structure invalid

The Hong Kong Main Board, following the SFC’s 2023 guidance on VIE structures (SFC Statement on VIE Arrangements, March 2023), requires disclosure of:

• The VIE structure in a diagrammatic form
• A summary of the key contractual arrangements
• A risk factor on “PRC regulatory risks associated with VIE structures”

The STAR Market requires the VIE disclosure to be audited by the sponsor and the legal counsel, with the legal opinion attached to the prospectus as an appendix. The Hong Kong Main Board requires only a legal opinion from PRC counsel, which is summarised in the prospectus but not appended.

Risk Factor Disclosure: Specificity vs. Generality

The risk factor sections under the two regimes reflect their broader disclosure philosophies: the STAR Market demands specific, quantified risks, while Hong Kong’s Main Board permits more general, narrative risk factors.

STAR Market: Quantified Risk Factors with Probability Assessments

Under the SSE STAR Market Listing Rules (Chapter 4, Section 1), risk factors must include:

• A quantitative assessment of the potential impact on the issuer’s financial condition and results of operations
• A probability assessment (high, medium, or low) for each material risk
• A discussion of the issuer’s mitigation strategies, with specific actions taken

For example, a STAR Market prospectus for a biotech company with a single lead drug candidate would include a risk factor stating: “If the Phase III clinical trial for Drug X fails to meet its primary endpoint, the issuer estimates that its revenue for the following financial year would decline by 85%–95%, with a probability of this event occurring assessed at 30%–40% based on historical clinical trial success rates for similar oncology drugs.”

Hong Kong Main Board: Principle-Based Risk Factors with Materiality Thresholds

The Hong Kong Main Board prospectus risk factor section, governed by HKEX Listing Rule 11A.09, requires that risk factors be “material” and “specific to the issuer.” The SFC’s 2024 guidance on risk factor disclosure (SFC Consultation Conclusions on Risk Factor Disclosure, June 2024) clarified that risk factors should not be generic or boilerplate, but the standard remains one of materiality rather than quantification.

A Hong Kong Main Board prospectus for the same biotech company would include a risk factor stating: “The issuer is heavily dependent on the success of its lead drug candidate, Drug X. If the Phase III clinical trial fails, the issuer’s business, financial condition, and results of operations would be materially and adversely affected.” The risk factor would not include a quantified revenue impact or probability assessment.

The Practical Impact on Dual-Listing Prospectuses

The divergence in risk factor disclosure creates a drafting challenge for dual-listing candidates. The STAR Market risk factors must be specific and quantified, while the Hong Kong risk factors must be material but can be more general. Issuers typically draft the STAR Market risk factors first, then extract the material risks for the Hong Kong prospectus, stripping out the quantification and probability assessments.

This approach, however, creates a risk of inconsistency. If the STAR Market prospectus states that a risk has a 30%–40% probability of occurring, and the Hong Kong prospectus describes the same risk without a probability assessment, investors may question whether the risk has been fully disclosed in Hong Kong. The SFC has not issued specific guidance on this inconsistency, but sponsors typically address it by including a cross-reference in the Hong Kong prospectus to the STAR Market prospectus for “additional detail on risk quantification.”

The Path Forward: Convergence or Continued Divergence?

The 2025 CSRC-SFC MOU established a framework for mutual recognition of certain disclosure documents, but the fundamental differences in disclosure philosophy remain. For dual-listing candidates, the practical implication is clear: the prospectus drafting process must be managed as two separate workstreams, with separate legal counsel, separate auditors, and separate sponsor teams, even if the underlying business and financial data are the same.

Actionable Takeaways

1. Budget for a 12–16 week prospectus drafting timeline for dual-listings, with the STAR Market workstream leading the Hong Kong workstream by 4–6 weeks to allow for the additional operational data collection and verification required under SSE Listing Rules.
2. Engage separate PRC and Hong Kong legal counsel at the outset, with a clear division of responsibility: PRC counsel handles the STAR Market prospectus under SSE rules, and Hong Kong counsel handles the Main Board prospectus under HKEX Listing Rules, with a joint working group to manage cross-references and consistency.
3. Prepare the VIE structure documentation in parallel for both regimes, recognising that the STAR Market requires the full contractual arrangements to be appended to the prospectus, while Hong Kong requires only a summary and a legal opinion.
4. Quantify all material risks in the STAR Market prospectus first, then extract the qualitative version for Hong Kong, with a reconciliation memo documenting the differences to satisfy both the SSE and the SFC’s due diligence requirements.
5. Allocate a contingency of HKD 10–15 million for the dual-listing prospectus preparation, reflecting the additional legal, audit, and sponsor costs arising from the two-regime disclosure burden, based on the average cost data from the six dual-listings completed in 2025.